#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12866	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2255	558.1	0	.	n	.	0	A69G	SNP	69	69	A	483	483	G	630	G	551	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12866	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2255	558.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1864	1864	T	736	T	631	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12866	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2255	558.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1598	1598	C	857	C	729	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23782	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3788	616.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1810	1810	A	712	A	647	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23782	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3788	616.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2444	2444	C	689	C	603	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23782	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3788	616.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2518	2518	A	778	A	646	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23782	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3788	616.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3070	3070	C	762	C	656	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	952	folP	852	852	99.88	folP.l15.c30.ctg.1	1826	50.6	0	.	p	.	0	E151K	NONSYN	451	453	GAA	970	972	AAA	98;98;97	A;A;A,G	88;89;88,1	.	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	952	folP	852	852	99.88	folP.l15.c30.ctg.1	1826	50.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1201	1203	AGC	121;121;127	A;G;C	101;102;107	folP.WHO_M_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	2378	gyrA	2751	2751	99.89	gyrA.l6.c4.ctg.1	3476	66.3	0	.	p	.	0	K261del	DEL	781	781	A	1187	1187	A	84	A	76	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	2378	gyrA	2751	2751	99.89	gyrA.l6.c4.ctg.1	3476	66.3	1	SNP	p	S91F	0	.	.	271	273	TCC	677	679	TCC	84;85;84	T;C;C	78;79;78	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	2378	gyrA	2751	2751	99.89	gyrA.l6.c4.ctg.1	3476	66.3	1	SNP	p	D95N	0	.	.	283	285	GAC	689	691	GAC	92;92;92	G;A;C	85;85;85	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	2378	gyrA	2751	2751	99.89	gyrA.l6.c4.ctg.1	3476	66.3	1	SNP	p	D95G	0	.	.	283	285	GAC	689	691	GAC	92;92;92	G;A;C	85;85;85	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	738	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1228	57.8	1	SNP	p	G45D	0	.	.	133	135	GGC	404	406	GGC	110;111;111	G;G;C	93;93;92	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	500	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	919	52.8	0	.	n	.	0	A197.	DEL	197	197	A	579	579	A	139	A	118	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	2274	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2994	73.1	1	SNP	p	D86N	0	.	.	256	258	GAC	635	637	GAC	105;105;105	G;A,T;C	96;96,1;97	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	2274	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2994	73.1	1	SNP	p	S87R	0	.	.	259	261	AGT	638	640	AGT	104;104;104	A;G;T	96;97;97	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	2274	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2994	73.1	1	SNP	p	S87W	0	.	.	259	261	AGT	638	640	AGT	104;104;104	A;G;T	96;97;97	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	2274	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2994	73.1	1	SNP	p	S87I	0	.	.	259	261	AGT	638	640	AGT	104;104;104	A;G;T	96;97;97	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	2274	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2994	73.1	1	SNP	p	S88P	0	.	.	262	264	TCC	641	643	TCC	104;104;100	T;C;C	96;97;92	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2050	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2928	67.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1650	1652	GGC	42;42;42	G;G;C	40;40;40	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	2386	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2338	98.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1276	1278	GCA	162;163;163	G;C;A	138;142;142	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	2386	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2338	98.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1279	1281	ATC	159;160;160	A;T;C	142;143;143	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	2386	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2338	98.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1291	1293	GTG	156;153;151	G;T,C;G	139;134,1;135	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	2386	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2338	98.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1291	1293	GTG	156;153;151	G;T,C;G	139;134,1;135	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	2386	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2338	98.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1795	1797	ACC	82;81;80	A;C;C	74;73;72	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	2386	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2338	98.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1849	1851	GCG	60;58;58	G;C;G	56;53;53	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	2386	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2338	98.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1849	1851	GCG	60;58;58	G;C;G	56;53;53	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	2386	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2338	98.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1972	1974	GGC	30;30;30	G;G;C	30;30;30	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	2386	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2338	98.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1981	1983	GGC	27;27;27	G;G;C	26;27;27	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	2386	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2338	98.8	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1999	2001	CTG	29;28;29	C;T;G	26;24;25	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	4142	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	3313	121.4	0	.	p	.	0	A761V	NONSYN	2281	2283	GCA	2549	2551	GTA	151;144;139	G;T;A,G	126;121;120,1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	4142	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	3313	121.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1529	1531	CCG	58;58;58	C;C;G	54;54;53	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	964	porA	1146	1146	99.65	porA.l6.c30.ctg.1	1883	49.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	512	512	C	40	C	37	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	166	porB1a	984	100	95.0	porB1a.l6.c30.ctg.2	267	25.9	0	.	p	.	0	M18T	NONSYN	52	54	ATG	219	221	ACG	49;48;48	A;C;G	38;38;38	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	166	porB1a	984	100	95.0	porB1a.l6.c30.ctg.2	267	25.9	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	261	263	CAA	18;18;18	C;A;A	15;15;15	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1688	porB1b	1047	1047	97.61	porB1b.l15.c4.ctg.1	1450	113.6	0	.	p	.	0	N38E	NONSYN	112	114	AAT	389	391	GAA	137;134;139	G;A;A	127;123;128	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1688	porB1b	1047	1047	97.61	porB1b.l15.c4.ctg.1	1450	113.6	0	.	p	.	0	N134D	NONSYN	400	402	AAT	677	679	GAT	126;126;138	G;A;T	110;110;119	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1688	porB1b	1047	1047	97.61	porB1b.l15.c4.ctg.1	1450	113.6	0	.	p	.	0	P175S	NONSYN	523	525	CCA	800	802	TCA	177;176;176	T;C;A	146;143;143	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1688	porB1b	1047	1047	97.61	porB1b.l15.c4.ctg.1	1450	113.6	0	.	p	.	0	K207_K208del	DEL	619	619	A	896	896	A	151	A	132	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1688	porB1b	1047	1047	97.61	porB1b.l15.c4.ctg.1	1450	113.6	0	.	p	.	0	S217fs	FSHIFT	649	649	A	910	910	T	137	T,A	123,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1688	porB1b	1047	1047	97.61	porB1b.l15.c4.ctg.1	1450	113.6	1	SNP	p	G120K	1	.	.	358	360	AAG	635	637	AAG	124;125;127	A;A;G	111;112;114	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1688	porB1b	1047	1047	97.61	porB1b.l15.c4.ctg.1	1450	113.6	1	SNP	p	A121D	1	.	.	361	363	GAC	638	640	GAC	129;129;133	G;A;C	115;116;118	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1688	porB1b	1047	1047	97.61	porB1b.l15.c4.ctg.1	1450	113.6	1	SNP	p	D121N	0	.	.	361	363	GAC	638	640	GAC	129;129;133	G;A;C	115;116;118	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	6326	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4573	134.8	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1806	1808	AAT	142;145;148	A;A;T	128;130;131	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	510	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1309	38.2	1	SNP	p	V57M	1	.	.	169	171	ATG	728	730	ATG	70;68;69	A;T;G	62;60;61	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
